Boiron SA Total Liabilities
Boiron SA total liabilities. Based on the latest financial reports, Boiron SA (BOI) has total liabilities worth €210.03 Million EUR (≈ $245.55 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Boiron SA liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Boiron SA (2001–2025)
Total liabilities of Boiron SA from 2001 to 2025. This chart illustrates how Boiron SA's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Boiron SA's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Boiron SA Competitors by Total Liabilities
The table below lists competitors of Boiron SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Samhi Hotels Limited
NSE:SAMHI
|
India | Rs20.08 Billion |
|
Jiangxi Synergy Pharmaceutical Co Ltd
SHE:300636
|
China | CN¥927.61 Million |
|
Choil Aluminum
KO:018470
|
Korea | ₩218.84 Billion |
|
TrueLight
TWO:3234
|
Taiwan | NT$270.56 Million |
|
Zota Health Care LImited
NSE:ZOTA
|
India | Rs2.87 Billion |
|
Suzhou Kelida Bldg &
SHG:603828
|
China | CN¥3.37 Billion |
|
Dare Technology Co Ltd
SHE:000910
|
China | CN¥2.32 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down Boiron SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Boiron SA asset portfolio.
Liquidity & Leverage Metrics
Boiron SA Total Liabilities Ratios Explained
Boiron SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Boiron SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Boiron SA (2001–2025)
The table below shows the annual total liabilities of Boiron SA from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €210.03 Million ≈ $245.55 Million |
+6.00% |
| 2024-12-31 | €198.15 Million ≈ $231.66 Million |
-0.28% |
| 2023-12-31 | €198.70 Million ≈ $232.30 Million |
-14.41% |
| 2022-12-31 | €232.15 Million ≈ $271.40 Million |
-2.84% |
| 2021-12-31 | €238.93 Million ≈ $279.33 Million |
-12.37% |
| 2020-12-31 | €272.65 Million ≈ $318.76 Million |
+5.34% |
| 2019-12-31 | €258.82 Million ≈ $302.59 Million |
-7.90% |
| 2018-12-31 | €281.03 Million ≈ $328.56 Million |
-0.66% |
| 2017-12-31 | €282.91 Million ≈ $330.76 Million |
-0.88% |
| 2016-12-31 | €285.44 Million ≈ $333.70 Million |
+2.16% |
| 2015-12-31 | €279.40 Million ≈ $326.65 Million |
-3.54% |
| 2014-12-31 | €289.67 Million ≈ $338.65 Million |
+5.06% |
| 2013-12-31 | €275.73 Million ≈ $322.36 Million |
+22.48% |
| 2012-12-31 | €225.12 Million ≈ $263.19 Million |
+2.82% |
| 2011-12-31 | €218.96 Million ≈ $255.98 Million |
+2.08% |
| 2010-12-31 | €214.50 Million ≈ $250.77 Million |
+2.80% |
| 2009-12-31 | €208.66 Million ≈ $243.94 Million |
+8.76% |
| 2008-12-31 | €191.86 Million ≈ $224.30 Million |
+7.51% |
| 2007-12-31 | €178.45 Million ≈ $208.62 Million |
-1.94% |
| 2006-12-31 | €181.97 Million ≈ $212.74 Million |
-7.80% |
| 2005-12-31 | €197.37 Million ≈ $230.75 Million |
+55.50% |
| 2004-12-31 | €126.93 Million ≈ $148.39 Million |
+28.94% |
| 2003-12-31 | €98.44 Million ≈ $115.09 Million |
+2.27% |
| 2002-12-31 | €96.26 Million ≈ $112.54 Million |
+11.04% |
| 2001-12-31 | €86.69 Million ≈ $101.35 Million |
-- |
About Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more